Showing 5071-5080 of 21466 results for "".
- Patient-Centered Opioid Tapering for Chronic Painhttps://reachmd.com/news/opioid-tapering-chronic-pain/2487816/Key Takeaways Taper success at 12 months was similar with taper only, taper plus pain-CBT, and taper plus CPSMP. Taper success reflected either a substantial MEDD reduction without more pain or no MEDD increase with lower pain intensity. Study
- Study Links Non-Ablative Fractional Laser Treatment to Epigenetic Remodeling of Aging Skinhttps://reachmd.com/news/study-links-non-ablative-fractional-laser-treatment-to-epigenetic-remodeling-of-aging-skin/2487808/A new study published in Scientific Reports provides in vivo human evidence that treatment with a 1940-nm non-ablative fractional laser may induce durable epigenetic changes associated with skin rejuvenation, expanding understanding of the biologic effects of energy-based devices beyond
- Medicaid ACOs and Pediatric Behavioral Health Carehttps://reachmd.com/news/medicaid-acos-and-pediatric-behavioral-health-care/2487803/Key Takeaways Medicaid ACO implementation was associated with higher reported unmet mental health needs among Medicaid- or CHIP-insured children with behavioral health conditions. No association was observed for having a personal physician or nurse, me
- Sex Differences in Acute Chest Pain Care in a US ED Cohorthttps://reachmd.com/news/sex-differences-in-acute-chest-pain-care-in-a-us-ed-cohort/2487804/Key Takeaways Lower 30-day death or myocardial infarction was observed in women than men, and adjusted odds remained lower after accounting for cardiovascular disease confounders and initial hs-cTn. Women also had lower 30-day hospitalization and lower
- CAR-Like Tregs Suppress Allergic Asthma in Micehttps://reachmd.com/news/car-like-tregs-suppress-allergic-asthma-in-mice/2487798/Key Takeaways In birch pollen-sensitized mice, transfer of CAlleR Tregs was associated with less allergic inflammation, less mucus production, and better lung function after allergen re-exposure. In previously unexposed mice, receipt of CAlleR Tregs be
- Ketogenic Diet Trial Reports Metabolic And Psychiatric Gains In Psychosishttps://reachmd.com/news/ketogenic-diet-trial-reports-metabolic-and-psychiatric-gains-in-psychosis/2487799/Key Takeaways One month of ketogenic diet versus diet-as-usual was associated with statistically significant metabolic improvement. Among participants who continued for four months, sustained metabolic improvement, lower depression and schizophrenia sy
- Propionic Acid Trial Reports Biomarker Signal in Multiple Sclerosishttps://reachmd.com/news/propionic-acid-trial-reports-biomarker-signal-in-multiple-sclerosis/2487802/Key Takeaways Adjunctive propionic acid was associated with a lower serum neurofilament light readout at 90 days, including a reported 17.9% reduction. The finding came from a double-blind, randomized, placebo-controlled phase 2b trial in adults with c
- High-Dose Vitamin D May Ease Chemotherapy- and Radiation-Related Skin Toxicities: Analysishttps://reachmd.com/news/high-dose-vitamin-d-may-ease-chemotherapy-and-radiation-related-skin-toxicities/2487809/High-dose oral vitamin D may offer an option for patients experiencing chemotherapy- and radiation-induced skin toxicities, according to a multicenter case series published in JAMA Dermatology.
- Recurrent Anaphylaxis Linked to Defensin Sensitizationhttps://reachmd.com/news/recurrent-anaphylaxis-linked-to-defensin-sensitization/2487774/Key Takeaways A case report about one 34-year-old man described 3 grade IV anaphylactic episodes after different meals in October 2022, one year later, and August 2025, with the diagnostic narrative ultimately converging on a defensin-related trigger hypothesis. Comp
- Single Early Pirarubicin After Nephroureterectomy Reduces Bladder Recurrencehttps://reachmd.com/news/single-early-pirarubicin-after-nephroureterectomy-reduces-bladder-recurrence/2487777/Key Takeaways Higher 3-year relapse-free survival was observed with pirarubicin than with observation. JCOG1403 was a randomized phase 3 study across 44 institutes that enrolled adults aged 20-80 years with previously untreated clinical stage 0a-III di